Biohaven is a leading biopharmaceutical company dedicated to discovering, developing, and commercializing innovative treatments that have the potential to transform lives. With a focus on key therapeutic areas such as neuroscience, immunology, and oncology, Biohaven is at the forefront of medical research. Central to their mission is the execution of clinical trials, which are vital for evaluating the safety and efficacy of new medications. These trials take place in medical centers and clinics globally, involving volunteers who play an essential role in advancing medical science.

Biohaven ensures a transparent and supportive experience for participants, helping them navigate the screening process and the steps necessary to join a clinical trial. The company prioritizes the well-being of participants, providing a framework that upholds their rights and safety as outlined by the U.S. Food and Drug Administration (FDA). By participating in Biohaven’s clinical trials, individuals not only gain access to potential new treatment options but also contribute to groundbreaking research aimed at improving healthcare outcomes.